Apellis names exec to lead Europe operations

Apellis Pharmaceuticals Inc. is expanding into Europe and has hired an executive to oversee those operations. Thomas Lackner joined Crestwood, Ky.-based Apellis as senior vice president, head of Europe. In his new role, Thomas will build out the launch organization in Europe for APL-2, Apellis' signature treatment. APL-2 is a synthetic peptide that can help treat autoimmune and inflammatory diseases, so me of which have no meaningful treatment. Apellis (Nasdaq:APLS) is conducting late-stage clinical…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news